Amazines Free Article Archive - Monday, October 02, 2023
Read about the most recent changes and happenings at
Log into your account or register as a new author. Start submitting your articles right now!
Search our database for articles.
Subscribe to receive articles emailed straight to your email account. You may choose multiple categories.
View our newest articles submitted by our authors.
View our most top rated articles rated by our visitors.
* Please note that this is NOT the ARTICLE manager
Add a new EZINE, or manage your EZINE submission.
Add fresh, free web content to your site such as newest articles, web tools, and quotes with a single piece of code!
Home What's New? Submit/Manage Articles Latest Posts Top Rated Article Search
Subscriptions Manage Ezines
 Article Archive
 Advertising (133564)
 Advice (161668)
 Affiliate Programs (34799)
 Art and Culture (73853)
 Automotive (145708)
 Blogs (75610)
 Boating (9851)
 Books (17223)
 Buddhism (4130)
 Business (1330527)
 Business News (426444)
 Business Opportunities (366517)
 Camping (10973)
 Career (72797)
 Christianity (15848)
 Collecting (11638)
 Communication (115088)
 Computers (241949)
 Construction (38960)
 Consumer (49953)
 Cooking (17081)
 Copywriting (6733)
 Crafts (18203)
 Cuisine (7549)
 Current Affairs (20316)
 Dating (45908)
 EBooks (19703)
 E-Commerce (48258)
 Education (185514)
 Electronics (83522)
 Email (6438)
 Entertainment (159849)
 Environment (28952)
 Ezine (3040)
 Ezine Publishing (5453)
 Ezine Sites (1551)
 Family & Parenting (111007)
 Fashion & Cosmetics (196597)
 Female Entrepreneurs (11853)
 Feng Shui (134)
 Finance & Investment (310616)
 Fitness (106469)
 Food & Beverages (63042)
 Free Web Resources (7941)
 Gambling (30227)
 Gardening (25202)
 Government (10517)
 Health (630113)
 Hinduism (2206)
 Hobbies (44083)
 Home Business (91611)
 Home Improvement (251209)
 Home Repair (46241)
 Humor (4721)
 Import - Export (5458)
 Insurance (45104)
 Interior Design (29617)
 International Property (3488)
 Internet (191027)
 Internet Marketing (146687)
 Investment (22861)
 Islam (1161)
 Judaism (1352)
 Law (80504)
 Link Popularity (4596)
 Manufacturing (20912)
 Marketing (99312)
 MLM (14140)
 Motivation (18233)
 Music (26999)
 New to the Internet (9496)
 Non-Profit Organizations (4048)
 Online Shopping (129734)
 Organizing (7813)
 Party Ideas (11855)
 Pets (38167)
 Poetry (2229)
 Press Release (12689)
 Public Speaking (5641)
 Publishing (7565)
 Quotes (2407)
 Real Estate (126644)
 Recreation & Leisure (95491)
 Relationships (87674)
 Research (16182)
 Sales (80348)
 Science & Technology (110287)
 Search Engines (23514)
 Self Improvement (153298)
 Seniors (6220)
 Sexuality (36010)
 Small Business (49310)
 Software (83032)
 Spiritual (23512)
 Sports (116154)
 Tax (7663)
 Telecommuting (34070)
 Travel & Tourism (308272)
 UK Property Investment (3123)
 Video Games (13382)
 Web Traffic (11790)
 Website Design (56918)
 Website Promotion (36662)
 World News (1000+)
 Writing (35844)
Author Spotlight

hello my name is Michael Campbell, I producer music for a living my company name is deal figure ente...more

I'm a full-time Writer, dreamer and chief executive manager. I write to release my true stories in t...more

I am in Nepalest tourism industery working since 2000 as a trekking porter to the senior tour leader...more

Suman Aryal is a skilled tour and trekking operator with expertise in organizing and writing itinera...more

I am an essay writer with vast experience in data analysis, PowerPoint writing and research paper ed...more

Injectafer for iron deficiency anemia by Clinnovo Research Labs

Article Author Biography
Injectafer for iron deficiency anemia by
Article Posted: 10/10/2013
Article Views: 871
Articles Written: 26
Word Count: 823
Article Votes: 2
AddThis Social Bookmark Button

Injectafer for iron deficiency anemia

Education,Health,Science & Technology
Ferric carboxymaltose injection with the brand name Injectafer is a parental iron replacement product which was approved by USFDA in July 2013, for the treatment of iron deficiency anemia in adults who have showed intolerance to oral iron or have had a poor response to oral iron. Injectafer is also indicated for iron deficiency anemia in adult patients with non-dialysis dependent chronic kidney disease (NND-CKD).

Injectafer was developed by Luitpold pharmaceutical Inc, a Daiichi Sankyo Group Company, headquartered in Shirley, New York. The Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets.

Iron is a mineral that is very much needed by the body to produce red blood cells. When the body does not get enough iron, it cannot produce the required number of red blood cells and this condition is called iron deficiency anemia. Iron-deficiency can occur due to insufficient dietary intake and absorption of iron, and/or loss of iron as a result ofinternal bleeding which can originate from a range of sources such as the intestinal, uterine or urinary tract. Thus theoccurrence of iron deficiency anemia can be the result of our body not making enough red blood cells or due to bleeding that causes loss of red blood cells more quickly than they can be replaced. Iron deficiency anemia affect women more often than men.Iron deficiency anemia ischaracterized by the signs of pallor and/or symptoms of fatigue, light-headedness, and weakness that are usuallynon-specific. Pallor is a condition of the skin becoming pale as a result of reduced amounts of oxyhaemoglobin in the skin or mucous membrane.

Injectafer with active ingredient ferric carboxymaltose is a dark brown, sterile, aqueous, isotonic colloidal solution for intravenous injection. The dosage of Injectafer is expressed as milligram of elemental iron.The recommended dose of Injectafer is 15 mg/kg with a total cumulative dose not exceeding 1500mg of elemental iron. Injectafer can be given in two separate doses for atleast 7 days. Each mL of Injectafer contains 50 mg of elemental iron. Injectafer is available in 15 mL single-use vials containing 750mg of elemental iron. Injectafer can be administered intravenously either as an undiluted slow intravenous push or by infusion. Injectafer treatment may be repeated if iron deficiency anemia reoccurs.

The FDA approval of Injectafer was based on the safety and efficacy that was evaluated in two randomized, open label, comparator controlled clinical trials (Trial1 and Trial2).Trial1 included iron deficiency anemia patients who were intolerant to oral iron or have had unsatisfactory response to oral iron for a 14 day period. They were then randomised into two groups and given twice daily dose of 750 mg Injectafer for group 1 and thrice daily of 325 mg oral/IV ironfor group 2, for another 14 days. On day 35, the mean increase of haemoglobin from baseline was found to be 2.90 g/dL and 2.16 g/dL for Injectafer and oral/IV iron respectively. Trial2 was on iron deficiency anemia patients with non-dialysis dependent chronic kidney disease.Trial 2 compared thrice daily of 750 mg Injectafer to five daily doses of 200 mg venofer.On Day 56,the mean increase of haemoglobin from baseline was found to be 1.13 g/dL and 0.92 g/dL for Injectafer and venofer respectively. Venofer is an iron sucrose injection to treat iron deficiency anemia patients with chronic kidney disease in adults and paediatric children older than 2 years. Venofer is administered as a total cumulative dose of 1000 mg as a 200 mg slow IV injection undiluted over 2 to 5 minutes on 5 different occasions.

The major side effects reported for Injectafer are hypersensitivity reactions, injection site discoloration, hypertension, nausea, vomiting, dizziness, head ache, and constipation. Some of the adverse reactions reported are abdominal pain, diarrhoea, rash, paraesthesia, and sneezing. Transient decreases in blood phosphorus levels have also been reported.Also one should pay utmost caution during administration of IV Injectafer to avoid any extravasation of the drug since the brown discoloration at the extravasation site may be long lasting; extravasation is the leakage of intravenous drugs from the vein into the surrounding tissue. If extravasation occurs, one should discontinue the drug administration at that site.

Injectafer is a newoption for adults who have intolerance to oral iron or have had a poor response to oral iron. It is also proved to be effective in patients with Non-Dialysis Dependent Chronic Kidney Disease. Clinical trials have also confirmed thatInjectafershowed a gradual increase in ferritin levels in the blood with no renal elimination of iron.

Clinnovo is a clinical innovation company. It is pioneer CRO industry in India. Clinnovo offers professional Clinical Research Course, clinical data management course , SAS and imaging training. Clinnovo has been serving different bio-pharma industries across the world with excellence and high quality. For more information contact at +91 9912868928, 040 64635501

Related Articles - new drug, iron deficiency, Luitpold, Injectafer, iron deficiency, Clinical Research, Clinical Data Management, SAS, Training, anemia, pharmaceutical,

Email this Article to a Friend!

Receive Articles like this one direct to your email box!
Subscribe for free today!

 Rate This Article  
Completely useless, should be removed from directory.
Minimal useful information.
Decent and informative.
Great article, very informative and helpful.
A 'Must Read'.


Do you Agree or Disagree? Have a Comment? POST IT!

 Reader Opinions 
Submit your comments and they will be posted here.
Make this comment or to the Author only:
*Your email will NOT be posted. This is for administrative purposes only.
Comments: *Your Comments WILL be posted to the AUTHOR ONLY if you select PRIVATE and to this PUBLIC PAGE if you select PUBLIC, so write accordingly.
Please enter the code in the image:

 Author Login 
Register for Author Account


Advertiser Login


   Limited Time $60 Offer!
   90  Days-1.5 Million Views  


Great Paranormal Romance


At LeadGenerators, we specialise in content-led Online Marketing Strategies for our clients in the t...more

I am the editor of QUAY Magazine, a B2B publication based in the South West of the UK. I am also the...more

After 60-plus years of living, I am just trying to pass down some of the information that I have lea...more

Steve Bye is currently a fiction writer, who published his first novel, ‘Looking Forward Through the...more

A postgraduate in Fashion Technology. Shalini is a writer at heart! Writing for her is an expression...more

James is a Research Enthusiast that focuses on the understanding of how things work and can be impro...more

Stevert Mckenzie, Travel Enthusiast. ...more

Author of four books and two screenplays; frequent magazine contributor. I have four other books "in...more

I have been involved in nutrition and weight management for over 12 years and I like to share my kn...more

Ryan Jones owns and operates this website, Having worked in the computer industry sin...more

HomeLinksAbout UsContact UsTerms of UsePrivacy PolicyFAQResources
Copyright © 2023, All rights reserved.
Some pages may contain portions of text relating to certain topics obtained from under the GNU FDL license